Class II alloantibody and mortality in simultaneous liver-kidney transplantation.
about
The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant RecipientsClinical significance of donor-specific human leukocyte antigen antibodies in liver transplantationHLA antibody detection with solid phase assays: great expectations or expectations too great?ABO-compatible liver allograft antibody-mediated rejection: an update.The role of donor-specific HLA alloantibodies in liver transplantation.Antibody-mediated rejection as a contributor to previously unexplained early liver allograft lossCodominant Role of Interferon-γ- and Interleukin-17-Producing T Cells During Rejection in Full Facial Transplant Recipients.Protecting the Kidney in Liver Transplant Recipients: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.Longterm renal allograft survival after sequential liver-kidney transplantation from a single living donor.Successful Simultaneous Liver-Kidney Transplantation in the Presence of Multiple High-Titered Class I and II Antidonor HLA Antibodies.Proposed Diagnostic Criteria for Chronic Antibody-Mediated Rejection in Liver Allografts.Donor-specific alloantibodies are associated with fibrosis progression after liver transplantation in hepatitis C virus-infected patients.Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis C.Prevalence, incidence and risk factors for donor-specific anti-HLA antibodies in maintenance liver transplant patients.Transplantation: Alloantibodies in simultaneous liver-kidney transplantation.2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.Donor-specific anti-HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation.Donor-specific antibodies after pediatric liver transplantation: a cross-sectional study of 50 patients.Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation.
P2860
Q26774993-BCAD9679-3002-434F-8F54-1AE33F33D58CQ26780271-E956F3B5-C162-448F-9AD6-C61A4D0E333FQ27015921-E1F4D5E8-A20F-4BEF-9335-379239321C68Q33422561-A6CBD981-5D6A-428D-863F-01536F50558FQ35547041-B0FEC3F6-7AB5-4AC2-A0CE-FC3EEA13F615Q36216606-BA63B94B-59D5-4D08-BA8D-65FCAD597A4DQ37164579-E623D4A3-B9B8-4243-BE7F-AA2133EB73C5Q38757060-48B24909-49FD-4714-B2EA-2A71BBD77452Q38793619-47BE692A-6963-43CF-9EF3-ACBB9CBAA05FQ39090125-EFB60C3A-4917-4AC5-8CB5-27A11022488CQ40429580-F2EC0065-9F38-473C-89D2-AF8C8CCFC542Q42228443-BD52A8E9-50F2-45FB-AD20-9C18AFF10653Q42233093-078A5142-725E-456A-8B42-55CAB591F34CQ44604343-2413A212-8F56-41C4-BEE4-6FB573754440Q46039154-9A35286A-E9A2-4FA2-8E20-87ECAEE165B4Q46360525-773AEBBB-7974-4372-A1FE-A8BC4083616CQ48202160-8FAB85C3-2F0B-4846-831A-AFED74ACD737Q50266397-3EB0BFD8-A119-4028-958F-0B3EEC5C6C7DQ50895880-425026F2-E932-41A4-ACDA-A90540488CAA
P2860
Class II alloantibody and mortality in simultaneous liver-kidney transplantation.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Class II alloantibody and mortality in simultaneous liver-kidney transplantation.
@ast
Class II alloantibody and mortality in simultaneous liver-kidney transplantation.
@en
type
label
Class II alloantibody and mortality in simultaneous liver-kidney transplantation.
@ast
Class II alloantibody and mortality in simultaneous liver-kidney transplantation.
@en
prefLabel
Class II alloantibody and mortality in simultaneous liver-kidney transplantation.
@ast
Class II alloantibody and mortality in simultaneous liver-kidney transplantation.
@en
P2093
P2860
P356
P1476
Class II alloantibody and mortality in simultaneous liver-kidney transplantation.
@en
P2093
B M Susskind
G B Klintmalm
J G O'Leary
S M Shiller
P2860
P304
P356
10.1111/AJT.12147
P407
P577
2013-02-22T00:00:00Z